These studies did not compare models measuring IGFBP-1 alone or in combination with routinely available parameters associated with NAFLD such as age, gender, measures of obesity, glucose, insulin, lipids, liver enzymes to models without IGFBP-1. This evidence concerns the gene IGFBP1 and metabolic dysfunction-associated steatotic liver disease.